Search Results - subject:"cervical intraepithelial neoplasia"

Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model

Schobert, Deniz; Remy, Vanessa; Schoeffski, Oliver - In: Health Economics Review 2 (2012) 19, pp. 1-10

intraepithelial neoplasia (CIN) and genital warts. The evaluated vaccination strategies were all found to be cost-effective. Future … cervical cancer screening programmes in Germany will substantially reduce the incidence of cervical cancer, cervical …

Persistent link: https://www.econbiz.de/10010317168

Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model

Schobert, Deniz; Remy, Vanessa; Schoeffski, Oliver - In: Health economics review 2 (2012) 19, pp. 1-10

Persistent link: https://www.econbiz.de/10009752876

Evaluating the Epidemiology and Morbidity Burden Associated with Human Papillomavirus in Israel: Accounting for CIN1 and Genital Warts in Addition to CIN2/3 and Cervical Cancer

Shavit, Oren; Raz, Raanan; Stein, Michal; Chodick, Gabriel - In: Applied Health Economics and Health Policy 10 (2012) 2, pp. 87-97

cervical intraepithelial neoplasia (CIN) grades 1, 2 and 3 were 74, 27 and 36 per 100 000 females, respectively. Incidence of …

Persistent link: https://www.econbiz.de/10009647783

Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US: Analytic Framework and Review of the Literature

Insinga, Ralph P.; Dasbach, Erik J.; Elbasha, Elamin H. - In: PharmacoEconomics 23 (2005) 11, pp. 1107-1122

intraepithelial neoplasia (range $US700 million-$US2.3 billion). Only one study reported direct medical costs for anogenital warts …, there was a wide range across studies for estimates of the annual direct medical costs associated with cervical …

Persistent link: https://www.econbiz.de/10005243142